Pancreatic mucinous cystadenoma

Summary

Pancreatic mucinous cystadenoma (MONDO:0018523) is a disease and 1 clinical trial. A subtype of pancreatic cystadenoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: Unknown (Europe) [Orphanet-validated]
• Clinical trials: 1

Clinical features

Epidemiology

Prevalence records

13 prevalence record(s), Orphanet:

Type	Class	Value	Geography	Validation
Annual incidence	<1 / 1 000 000	0.01	Europe	Validated
Annual incidence	<1 / 1 000 000	0.006	Belgium	Validated
Annual incidence	<1 / 1 000 000	0.002	Bulgaria	Validated
Annual incidence	<1 / 1 000 000	0.002	Czech Republic	Validated
Annual incidence	<1 / 1 000 000	0.012	Finland	Validated
Annual incidence	<1 / 1 000 000	0.003	France	Validated
Annual incidence	<1 / 1 000 000	0.012	Germany	Validated
Annual incidence	<1 / 1 000 000	0.019	Italy	Validated
Annual incidence	<1 / 1 000 000	0.004	Portugal	Validated
Annual incidence	<1 / 1 000 000	0.024	Spain	Validated
Annual incidence	<1 / 1 000 000	0.006	Switzerland	Validated
Annual incidence	<1 / 1 000 000	0.019	Netherlands	Validated
Annual incidence	<1 / 1 000 000	0.004	United Kingdom	Validated

Identifiers

Disease identifiers

Field	Value
Canonical name	pancreatic mucinous cystadenoma
Mondo ID	MONDO:0018523
Orphanet	424053
DOID	DOID:7235, DOID:7735
NCIT	C5718
UMLS	C1335309
MedGen	277492
GARD	0021778
Anatomy (UBERON)	UBERON:0001264
Is cancer (heuristic)	no

Also known as: pancreas mucinous cystadenoma · pancreatic mucinous cystadenoma

Disease family

This is a subtype of pancreatic cystadenoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › adenoma › cystadenoma › pancreatic cystadenoma › pancreatic mucinous cystadenoma

Related subtypes (1): pancreatic serous cystadenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03884179	Not specified	UNKNOWN	Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy